In previous studies, researchers have found that the overexpression of SPEN was involved in drug responsiveness in breast cancer29, and significant downregulation of SF3B5 was revealed in acute myeloid leukemia patients30. This evidence concerns the gene SF3B5 and acute myeloid leukemia.